GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 89 filers reported holding GALENA BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $46,000 | -24.6% | 130,373 | 0.0% | 0.00% | -100.0% |
Q2 2016 | $61,000 | -65.5% | 130,373 | 0.0% | 0.00% | -50.0% |
Q1 2016 | $177,000 | -7.8% | 130,373 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $192,000 | -6.8% | 130,373 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $206,000 | -7.2% | 130,373 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $222,000 | +22.7% | 130,373 | 0.0% | 0.00% | +50.0% |
Q1 2015 | $181,000 | -8.1% | 130,373 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $197,000 | -28.6% | 130,373 | -2.8% | 0.00% | -50.0% |
Q3 2014 | $276,000 | -32.8% | 134,173 | 0.0% | 0.00% | -42.9% |
Q2 2014 | $411,000 | +22.7% | 134,173 | 0.0% | 0.01% | +16.7% |
Q1 2014 | $335,000 | – | 134,173 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
Perceptive Advisors | 200,000 | $302,000 | 0.02% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |